Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laina D Mercer

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Plos Neglected Tropical Diseases|September 30, 2020
Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian childrenMichael B Arndt, Jason L Cantera, Laina D Mercer, et al.
Atmospheric Environment (Oxford, England : 1994)|August 3, 2011
Comparing universal kriging and land-use regression for predicting concentrations of gaseous oxides of nitrogen (NOx) for the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)Laina D Mercer, Adam A Szpiro, Lianne Sheppard, et al.
BMC Medicine|October 12, 2017
Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in PakistanLaina D Mercer, Rana M Safdar, Jamal Ahmed, et al.
Plos Neglected Tropical Diseases|November 18, 2021
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection modelRahsan Erdem, Gwen Ambler, Mohamed Al-Ibrahim, et al.
The Journal of Infectious Diseases|July 22, 2020
Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence DataMaya Fraser, John M Miller, Kafula Silumbe, et al.
Vaccine|December 30, 2022
Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype compositionWolfgang Rennert, Musa Hindiyeh, Majd Allahham, et al.
NPJ Vaccines|November 25, 2025
One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in ThailandWeerapong Phumratanaprapin, Viravarn Luvira, Saranath Lawpoolsri, et al.
Plos One|December 29, 2018
Assessing the sensitivity of the polio environmental surveillance systemSteve J Kroiss, Maiwand Ahmadzai, Jamal Ahmed, et al.
Vaccine|August 11, 2025
Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)Viravarn Luvira, Saranath Lawpoolsri, Weerapong Phumratanaprapin, et al.
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Plos Neglected Tropical Diseases|September 30, 2020
Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian childrenMichael B Arndt, Jason L Cantera, Laina D Mercer, et al.
Atmospheric Environment (Oxford, England : 1994)|August 3, 2011
Comparing universal kriging and land-use regression for predicting concentrations of gaseous oxides of nitrogen (NOx) for the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)Laina D Mercer, Adam A Szpiro, Lianne Sheppard, et al.
BMC Medicine|October 12, 2017
Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in PakistanLaina D Mercer, Rana M Safdar, Jamal Ahmed, et al.
Plos Neglected Tropical Diseases|November 18, 2021
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection modelRahsan Erdem, Gwen Ambler, Mohamed Al-Ibrahim, et al.
The Journal of Infectious Diseases|July 22, 2020
Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence DataMaya Fraser, John M Miller, Kafula Silumbe, et al.
Vaccine|December 30, 2022
Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype compositionWolfgang Rennert, Musa Hindiyeh, Majd Allahham, et al.
NPJ Vaccines|November 25, 2025
One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in ThailandWeerapong Phumratanaprapin, Viravarn Luvira, Saranath Lawpoolsri, et al.
Plos One|December 29, 2018
Assessing the sensitivity of the polio environmental surveillance systemSteve J Kroiss, Maiwand Ahmadzai, Jamal Ahmed, et al.
Vaccine|August 11, 2025
Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)Viravarn Luvira, Saranath Lawpoolsri, Weerapong Phumratanaprapin, et al.
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Pageof 5